Rare diseases / Gene therapy


HBM contact: Dr Priyanka Belawat

Company status: private

Mahzi’s research and development efforts are focused exclusively on rare genetic neurodevelopmental disorders, a group of serious diseases with few or no treatment options. Many treatment modalities like RNA or DNA based therapies will be developed for such diseases.

© HBM Partners AG  |  Bundesplatz 1  |  6300 Zug, Switzerland  |  Phone  +41 43 888 7171